Stryker Corp. (SYK) Tops Q1 EPS by 2c, Offers Q2, FY Guidance

Stryker Corp. (NYSE: SYK) reported Q1 EPS of $1.11, $0.02 better than the analyst estimate of $1.09. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.38 billion.

Stryker Corp. sees Q2 2015 EPS of $1.15-$1.20, versus the consensus of $1.17.

Stryker Corp. sees FY2015 EPS of $4.95-$5.10, versus the consensus of $4.99.

For earnings history and earnings-related data on Stryker Corp. (SYK) click here.

You May Also Be Interested In

• Wolfe Research Downgrades Stryker (SYK) to Peerperform
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c